Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
about
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies.Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project.The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.Framework to construct and interpret latent class trajectory modellingBMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditionsCirculating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
P2860
Q33901167-E1DC35FA-F720-43EF-983A-02485161EA5AQ38730180-E8C14A85-5FD7-42DE-855A-1CB8A1B58C17Q38989776-84AE7121-7474-44BB-A17E-73028381F2E7Q40185822-344FD325-6498-4BB3-994C-A9BE198ACFA9Q47158154-65D8B767-716F-49F5-A79B-04B5F5EF9446Q49540308-556EB5B7-8CEE-43E5-96B6-988B3F32296FQ49787829-BF16503B-269D-4AAB-B773-4E24003B4677Q52605888-955B77D3-019A-48D6-80A6-F8FBAD2426F9Q53692565-C2E6B09E-E408-4C60-9BF7-3C6523032058Q57176852-496868BD-C5AE-462F-8A7C-C722557FCC49Q58749101-556D1819-40D0-454F-B42B-2AA0D7FAC47DQ58773054-2CF086B2-8820-44EC-844F-6F6CECA77484
P2860
Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prediagnostic Body Mass Index ...... e PLCO Cancer Screening Trial.
@en
type
label
Prediagnostic Body Mass Index ...... e PLCO Cancer Screening Trial.
@en
prefLabel
Prediagnostic Body Mass Index ...... e PLCO Cancer Screening Trial.
@en
P2093
P2860
P356
P1476
Prediagnostic Body Mass Index ...... e PLCO Cancer Screening Trial.
@en
P2093
Barry I Graubard
Gabriella Andreotti
Michael B Cook
Naji Younes
Scott P Kelly
Sean D Cleary
P2860
P356
10.1093/JNCI/DJW225
P407
P577
2016-10-20T00:00:00Z